Real-time enrollment status for this b-cell lymphoma clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 12:07 PM UTC
| NCT Number | NCT05006716 |
| Recruiting Status | Recruiting |
| Condition | B-Cell Lymphoma |
| Phase | Clinical Trial |
| Target Enrollment | 621 participants |
| Active Locations | 32 sites in the US |
| Sponsor | BeiGene |
| Last Updated on CT.gov | February 23, 2026 (1 week ago) |
As of March 2, 2026: Clinical trial NCT05006716 is currently recruiting participants. This clinical trial study for b-cell lymphoma is actively seeking new participants at 32 locations across the United States. The study is sponsored by BeiGene. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05006716 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 32 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05006716 was last updated 1 week ago (February 23, 2026). HelloStudys verifies this status automatically.